FDA Expands Remdesivir Approval for Patients at Risk of Severe COVID-19 Disease

Retrieved on: 2022-01-22 17:48:29

Tags for this article:

Click the tags to see associated articles and topics

FDA Expands Remdesivir Approval for Patients at Risk of Severe COVID-19 Disease. View article details on hiswai:

Excerpt

Gilead's remdesivir was granted expanded FDA approval to treat non-hospitalized adult and adolescent patients at high risk of severe or fatal ...

Article found on: www.contagionlive.com